Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Sight Sciences Announces $34M Patent Infringement Verdict Against Alcon And Its Hydrus Microstent For Microinvasive Glaucoma Surgery; Monetary Damages Comprised Of $5.5M In Lost Profits And $28.5M In Royalty Damages For Sales Of The Hydrus Microstent For The Period From Its Commercial Launch Through Trial

Author: Benzinga Newsdesk | April 29, 2024 08:06am

Posted In: SGHT